PALSONIFY is the first once-daily, oral therapy approved to treat acromegaly in the European Union
Approval based on strength of data from two pivotal Phase 3 studies studying PALSONIFY in both medical naïve and previously treated patients with acromegaly
Read more at globenewswire.com